|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA03010220
|
15S-hydroperoxy-PGD2
|
9S-hydroxy-11-oxo-15S-hydroperoxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010217
|
15S-hydroperoxy-PGE2
|
9-oxo-11R-hydroxy-15S-hydroperoxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010240
|
19-hydroxy-prostaglandin I2
|
6,9S-epoxy-11R,15S,19-trihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010024
|
19R-hydroxy-PGE2
|
9-oxo-11R,15S,19R-trihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010216
|
20-hydroxy-PGD2
|
9S,15S,20-trihydroxy-11-oxo-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010014
|
20-hydroxy-PGE2
|
9-oxo-11R,15S,20-trihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010012
|
6-keto PGE1
|
6,9-dioxo-11R,15S-dihydroxy-13E-prostenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010149
|
D17, 6-keto PGF1a
|
6-oxo-9S,11R,15S-trihydroxy-13E,17Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03010009
|
PGG2
|
9S,11R-epidioxy-15S-hydroperoxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
368.22
|
C20H32O6
|
|
LMFA03020059
|
20-COOH-10,11-dihydro-LTB4
|
(5R,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,14-trienedioic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
368.22
|
C20H32O6
|
|
LMFA03020061
|
20-dihydroxyleukotriene B4
|
(5R,6Z,8E,10E,12S,14Z)-5,12,20,20-tetrahydroxyicosa-6,8,10,14-tetraenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
368.22
|
C20H32O6
|
|
LMFA03020068
|
5(6)-Epoxy Prostaglandin E1
|
4-(3-{[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]methyl}oxiran-2-yl)butanoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
368.22
|
C20H32O6
|
|
LMFA03030014
|
11-Dehydro-thromboxane B2
|
(5E)-7-[(2R,3S,4S)-4-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-6-oxooxan-3-yl]hept-5-enoic acid
|
Eicosanoids [FA03]
|
Thromboxanes [FA0303]
|
368.22
|
C20H32O6
|
|
LMFA03030004
|
11-dehydro-TXB2
|
9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid
|
Eicosanoids [FA03]
|
Thromboxanes [FA0303]
|
368.22
|
C20H32O6
|
|
LMFA03030006
|
TXB3
|
9S,11,15S-trihydroxy-thromboxa-5Z,13E,17Z-trien-1-oic acid
|
Eicosanoids [FA03]
|
Thromboxanes [FA0303]
|
368.22
|
C20H32O6
|
|
LMFA03030016
|
Thromboxane B3
|
(5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid
|
Eicosanoids [FA03]
|
Thromboxanes [FA0303]
|
368.22
|
C20H32O6
|
|
LMFA03060046
|
5,12-diHPETE
|
5,12-dihydroperoxy-6,8,10,14-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
368.22
|
C20H32O6
|
|
LMFA03060047
|
5,15-diHPETE
|
5,15-dihydroperoxy-6,8,11,13-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
368.22
|
C20H32O6
|
|
LMFA03060097
|
5S,15S-diHPETE
|
5S,15S-dihydroperoxy-6E,8Z,11Z,13E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
368.22
|
C20H32O6
|
|
LMFA03060048
|
8,15-diHPETE
|
8,15-dihydroperoxy-5,9,11,13-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
368.22
|
C20H32O6
|
|
LMFA03060098
|
8S,15S-diHPETE
|
8S,15S-dihydroperoxy-5Z,9E,11Z,13E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
368.22
|
C20H32O6
|